POLE突变合并微囊性、伸长及碎片状(MELF)浸润模式可能与子宫内膜癌中国女性不良生存相关
在426例子宫内膜癌中国女性中检测POLE突变,发现38例(8.9%)存在POLE突变,PoLE突变与总生存改善相关(P=.047),但与无进展生存无显著关系(P=.45)。在POLE突变肿瘤中,MELF浸润模式与肿瘤复发或进展风险增加15.1倍相关(HR=15.1,95%CI=1.57-145.3,P=.018),而该现象在POLE野生型亚组中不存在(HR=0.90,95%CI=0.39-2.08,P=.80)。结论认为结合POLE突变状态与临床病理因素进行风险评估更准确。
要点
- POLE突变见于8.9%(38/426)的子宫内膜癌中国女性,与总生存改善相关(P=.047)。
- POLE突变肿瘤中MELF浸润模式与复发或进展风险增加相关(HR=15.1,95%CI=1.57-145.3,P=.018)。
- POLE野生型亚组中MELF模式与复发或进展风险无显著关联(HR=0.90,95%CI=0.39-2.08,P=.80)。
核心结论
- POLE突变与总生存改善相关,但结合POLE突变状态与临床病理因素进行风险评估比单独考虑临床病理因素更准确,可能有助于精准个体化治疗策略。
研究设计与样本
- 研究检测了426例子宫内膜癌中国女性的POLE突变,并结合组织学及分子特征(MELF浸润模式、组织学亚型、肿瘤分级、肌层浸润、p53蛋白及错配修复蛋白表达状态)分析其与生存和复发结局的关系。
主要发现
- 426例子宫内膜癌中38例(8.9%)检出POLE突变,最常见突变为P286R(31.6%)、V411L(15.8%)和Q453R(15.8%)。
- POLE突变与总生存改善相关(P=.047),但与无进展生存无统计学显著关系(P=.45)。
- 在POLE突变肿瘤中,MELF浸润模式与肿瘤复发或进展风险增加15.1倍相关(HR=15.1,95%CI=1.57-145.3,P=.018);该现象在POLE野生型亚组中不存在(HR=0.90,95%CI=0.39-2.08,P=.80)。
- 与无POLE突变的患者相比,携带POLE突变的患者中更高分期和更深肌层浸润也显示更高的风险。
临床怎么用
- 作者认为,在子宫内膜癌风险评估中结合POLE突变状态与已确立的临床病理因素比单独考虑临床病理因素更准确,可能有助于精准个体化治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: POLE mutation is a prognostic marker associated with excellent outcome in endometrial carcinoma (EC). However, these EC tumors frequently have aggressive histology. The aim of this study was to determine how to integrate the implications of POLE mutations into existing risk assessment strategies and further stratify patients. METHODS: We detected POLE mutations in a cohort of 426 ECs from Chinese women and observed their prognostic significance in terms of survival and recurrence outcomes in combination with histological and other molecular characteristics, including microcystic, elongated and fragmented (MELF) pattern invasion, histologic subtype, tumor grade, myometrial invasion and p53 protein and mismatch repair protein expression status. RESULTS: POLE mutations were identified in 38 of 426 ECs (8.9%). The most common mutations were P286R (31.6%), V411L (15.8%) and Q453R (15.8%). We confirmed that POLE mutation was associated with improved overall survival (P = .047), although it did not show a statistically significant relationship with progression-free survival (P = .45). Interestingly, further analyses indicated that in POLE-mutant tumors, MELF pattern invasion was associated with a 15.1-fold increase in tumor recurrence or progression risk (HR = 15.1, 95%CI = 1.57-145.3, P = .018), whereas this phenomenon was not present in the POLE-wild-type subgroup (HR = 0.90, 95%CI = 0.39-2.08, P = .80). Furthermore, higher staging and deeper myometrial invasion also showed much higher risk in patients harboring POLE mutations compared with those without POLE mutations. CONCLUSIONS: Although POLE mutation was associated with favorable overall survival, the combined consideration of POLE mutation status and established clinicopathologic factors in the risk assessment of endometrial cancer is more accurate than the consideration of clinicopathologic factors alone and might lead to precise and individualized therapeutic strategies.
引用
- He D, Wang H, Dong Y, et al. POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women. Gynecol Oncol. 2020. PMID: 32800323. doi:10.1016/j.ygyno.2020.07.102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。